Atlas Trials

Memantine for Recurrent Glioblastoma

Clinical trial NCT01260467 · TERMINATED

Trial details

NCT number
NCT01260467
Sponsor
University of Rochester
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma
Start date
2010-11-01
Primary completion
2014-04-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.